Heart stent study halted: new device fails to outperform standard care

NCT ID NCT03508219

Terminated Disease control Sponsor: ECRI bv Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 32 times

Summary

This study tested a special stent (BiOSS LIM C) for people with a severe blockage in the left main coronary artery, a critical heart vessel. The trial enrolled 130 participants and compared the stent to a performance goal based on standard stents. The study was terminated early because the new stent did not prove to be as safe or effective as the standard treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Centre FRA-001

Aix-en-Provence, France
Research Centre FRA-002

Saint-Denis, France
Research Centre FRA-003

Grenoble, France
Research Centre FRA-004

Bron, France
Research Centre ITA-001

Naples, Italy
Research Centre ITA-002

Ragusa, Italy
Research Centre ITA-003

Syracuse, Italy
Research Centre PL-001

Warsaw, Poland
Research Centre PL-002

Zabrze, Poland
Research Centre PL-003

Zabrze, Poland
Research Centre PL-004

Olsztyn, Poland
Research Centre PL-005

Poznan, Poland
Research Centre PL-006

Katowice, Poland
Research Centre PL-007

Krakow, Poland
Research Centre PL-008

Warsaw, Poland

Conditions

Explore the condition pages connected to this study.

CORONARY STENOSIS